Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Febrile Neutropenia × TKN732 × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1 Lymphoid 1 Classical hematology 1

Conditions

Patient Participation 1 Multiple Myeloma 1 Lymphoma 1 Febrile Neutropenia 1

Interventions

pegfilgrastim 2 pegylated granulocyte colony-stimulating factor 1 Vancomycin 1 TKN732 1 Linezolid 1 Levofloxacin 1 Filgrastim 1 Bevacizumab 1 Amoxicillin-Potassium Clavulanate Combination 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06116734 2023-11-03

Lapelga vs Gastrofil

London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's

Phase 3 Unknown

Classical hematologyLymphoidPlasma cell

Lymphoma, Multiple Myeloma, Patient Participation, Febrile Neutropenia

Data powered by HemOnc (CC BY 4.0) Colophon ⚡